Novo Nordisk A/S (NYSE:NVO)

125.47
BATS BZX Real-Time Price
As of 1:20pm ET
 -0.32 / -0.25%
Today’s Change
91.51
Today|||52-Week Range
127.79
+12.03%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 127.17, with a high estimate of 149.40 and a low estimate of 75.50. The median estimate represents a +1.36% increase from the last price of 125.47.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.80
Sales
$6.4B
Reporting Date
Feb 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.88%
 
 
 
 
 
 
Growthannually 5.80%
 
 
 
 
 
 

Sales

Growthquarterly 6.16%
 
 
 
 
 
 
Growthannually 12.12%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.